当前位置: X-MOL 学术Clin. Colorectal Cancer › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Colon Cancer Survivorship in Patients Who Have Received Adjuvant Chemotherapy
Clinical Colorectal Cancer ( IF 3.4 ) Pub Date : 2023-07-28 , DOI: 10.1016/j.clcc.2023.07.001
Meghana Kesireddy 1 , Laura Tenner 1
Affiliation  

The number of colon cancer survivors in the United States is increasing due to improved early detection, better treatments that extend survival, and the growing aging population who are at high risk for cancer. Following initial active treatment, colon cancer survivors experience a wide range of long-term physical, psychological, and socio-economic effects that impact their overall well-being. Healthcare providers caring for survivors need to prioritize not only monitoring for cancer recurrence but also optimizing their overall health through addressing these long-term effects; managing their comorbidities; promoting healthy behaviors (like exercise, nutrition, and weight loss); and screening for a second primary cancer depending on their risk. Personalized survivorship care plans should be formulated clearly outlining the roles of various healthcare providers involved in their care. Our review article focuses on these various aspects of colon cancer survivorship, including surveillance for cancer recurrence specific to those who received adjuvant chemotherapy with curative intent.



中文翻译:

接受辅助化疗患者的结肠癌生存率

由于早期检测的改进、延长生存期的更好的治疗方法以及癌症高风险人口的老龄化,美国结肠癌幸存者的数量正在增加。经过初步积极治疗后,结肠癌幸存者会经历一系列长期的身体、心理和社会经济影响,影响他们的整体健康。照顾幸存者的医疗保健提供者不仅需要优先考虑监测癌症复发,还需要通过解决这些长期影响来优化他们的整体健康状况;管理他们的合并症;促进健康行为(如锻炼、营养和减肥);并根据风险筛查第二原发癌症。应制定个性化的幸存者护理计划,明确概述参与护理的各个医疗保健提供者的作用。我们的综述文章重点关注结肠癌生存的各个方面,包括针对那些接受治疗性辅助化疗的患者的癌症复发监测。

更新日期:2023-07-28
down
wechat
bug